Research programme: RNA targeted small molecules - Evotec/Takeda
Latest Information Update: 28 Apr 2025
At a glance
- Originator Evotec SE; Takeda
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Apr 2025 No recent reports of development identified for research development in Unspecified in Germany
- 28 Apr 2025 No recent reports of development identified for research development in Unspecified in Japan
- 22 Mar 2021 Evotec and Takeda enters into collaboration to develop RNA targeted small molecules